D1000 Varejo Farma Participacoes (BSP:DMVF3) Beneish M-Score: -2.63 (As of Jun. 24, 2026)


BSP:DMVF3 D1000 Varejo Farma Participacoes SA BSP:DMVF3
78 GF Score
Price R$6.82
GF Value R$8.13
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is D1000 Varejo Farma Participacoes Beneish M-Score?

D1000 Varejo Farma Participacoes BSP:DMVF3 -1.16% 78 Beneish M-Score is -2.63 as of Jun. 24, 2026. GuruFocus rates BSP:DMVF3 with a GF Score™ of 78/100 and a GF Value™ of R$8.13 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 632 Healthcare Providers & Services companies, D1000 Varejo Farma Participacoes ranks better than 54.59% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.63 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for D1000 Varejo Farma Participacoes's Beneish M-Score or its related term are showing as below:

BSP:DMVF3' s Beneish M-Score Range Over the Past 10 Years
Min: -3.43   Med: -2.6   Max: -0.74
Current: -2.63

During the past 9 years, the highest Beneish M-Score of D1000 Varejo Farma Participacoes was -0.74. The lowest was -3.43. And the median was -2.60.


D1000 Varejo Farma Participacoes Beneish M-Score Historical Data

* Premium members only.

The historical data trend for D1000 Varejo Farma Participacoes's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

D1000 Varejo Farma Participacoes Beneish M-Score Chart

D1000 Varejo Farma Participacoes Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only -2.57 -2.45 -2.69 -2.69 -2.60

D1000 Varejo Farma Participacoes Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.67 -2.55 -2.34 -2.60 -2.63

D1000 Varejo Farma Participacoes Beneish M-Score Competitor Comparison

For the Pharmaceutical Retailers subindustry, D1000 Varejo Farma Participacoes's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


D1000 Varejo Farma Participacoes Beneish M-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, D1000 Varejo Farma Participacoes's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where D1000 Varejo Farma Participacoes's Beneish M-Score falls into.


BSP:DMVF3
78GF Score
D1000 Varejo Farma Participacoes SA BSP:DMVF3
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

D1000 Varejo Farma Participacoes Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of D1000 Varejo Farma Participacoes for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0048+0.528 * 1.0548+0.404 * 0.9493+0.892 * 1.2277+0.115 * 1.0205
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9338+4.679 * -0.074037-0.327 * 1.0892
=-2.63

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was R$268 Mil.
Revenue was 660.392 + 690.31 + 731.44 + 676.688 = R$2,759 Mil.
Gross Profit was 201.879 + 205.254 + 195.721 + 191.604 = R$794 Mil.
Total Current Assets was R$618 Mil.
Total Assets was R$1,979 Mil.
Property, Plant and Equipment(Net PPE) was R$591 Mil.
Depreciation, Depletion and Amortization(DDA) was R$139 Mil.
Selling, General, & Admin. Expense(SGA) was R$545 Mil.
Total Current Liabilities was R$585 Mil.
Long-Term Debt & Capital Lease Obligation was R$386 Mil.
Net Income was 1.515 + 9.406 + 7.572 + 5.456 = R$24 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = R$0 Mil.
Cash Flow from Operations was 28.657 + 53.877 + 40.258 + 47.658 = R$170 Mil.
Total Receivables was R$217 Mil.
Revenue was 568.327 + 621.188 + 544.483 + 513.175 = R$2,247 Mil.
Gross Profit was 169.67 + 173.707 + 171.407 + 167.801 = R$683 Mil.
Total Current Assets was R$572 Mil.
Total Assets was R$1,831 Mil.
Property, Plant and Equipment(Net PPE) was R$509 Mil.
Depreciation, Depletion and Amortization(DDA) was R$122 Mil.
Selling, General, & Admin. Expense(SGA) was R$475 Mil.
Total Current Liabilities was R$530 Mil.
Long-Term Debt & Capital Lease Obligation was R$295 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(268.025 / 2758.83) / (217.28 / 2247.173)
=0.097152 / 0.09669
=1.0048

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(682.585 / 2247.173) / (794.458 / 2758.83)
=0.303753 / 0.287969
=1.0548

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (618.418 + 591.464) / 1978.743) / (1 - (572.469 + 509.319) / 1831.43)
=0.38856 / 0.409321
=0.9493

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=2758.83 / 2247.173
=1.2277

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(122.447 / (122.447 + 509.319)) / (138.662 / (138.662 + 591.464))
=0.193817 / 0.189915
=1.0205

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(544.777 / 2758.83) / (475.183 / 2247.173)
=0.197467 / 0.211458
=0.9338

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((385.961 + 585.126) / 1978.743) / ((294.946 + 530.254) / 1831.43)
=0.49076 / 0.450577
=1.0892

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(23.949 - 0 - 170.45) / 1978.743
=-0.074037

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

D1000 Varejo Farma Participacoes has a M-score of -2.63 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.63 mean?
D1000 Varejo Farma Participacoes (BSP:DMVF3) has a Beneish M-Score of -2.63 as of Jun. 24, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on D1000 Varejo Farma Participacoes and its competitors. According to the industry distribution chart, D1000 Varejo Farma Participacoes ranks #287 out of 632 companies in the Healthcare Providers & Services industry, placing it in the top 45.4%.
Is D1000 Varejo Farma Participacoes' Beneish M-Score too high?
D1000 Varejo Farma Participacoes' current Beneish M-Score is -2.63. Based on the distribution chart, D1000 Varejo Farma Participacoes ranks #287 out of 632 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, D1000 Varejo Farma Participacoes has a GF Score™ of 78/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does D1000 Varejo Farma Participacoes' Beneish M-Score compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, D1000 Varejo Farma Participacoes ranks #287 out of 632 companies for Beneish M-Score. This puts D1000 Varejo Farma Participacoes in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Healthcare Providers & Services company?
A good Beneish M-Score depends on the Healthcare Providers & Services industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on D1000 Varejo Farma Participacoes and its competitors. D1000 Varejo Farma Participacoes's current Beneish M-Score is -2.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is D1000 Varejo Farma Participacoes stock overvalued right now?
Based on GuruFocus' analysis, D1000 Varejo Farma Participacoes (BSP:DMVF3) is currently considered Modestly Undervalued. The stock's GF Value™ is R$8.13, compared to a current price of R$6.82 — trading 16.1% below its estimated fair value. The current Beneish M-Score is -2.63. D1000 Varejo Farma Participacoes' overall GF Score™ is 78/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For D1000 Varejo Farma Participacoes (BSP:DMVF3), the current Beneish M-Score is -2.63 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is D1000 Varejo Farma Participacoes (BSP:DMVF3) Overvalued in 2026?

Based on GuruFocus' analysis, D1000 Varejo Farma Participacoes stock appears to be undervalued. The current stock price of R$6.82 is trading 16.1% below its estimated GF Value™ of R$8.13. GuruFocus considers D1000 Varejo Farma Participacoes to be Modestly Undervalued.

Key valuation signals for BSP:DMVF3:

  • Beneish M-Score: -2.63
  • GF Value™: R$8.13 vs. price of R$6.82 (16.1% below fair value)
  • GF Score™: 78/100 with 6 warning signs

No single metric tells the full story. See the BSP:DMVF3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


D1000 Varejo Farma Participacoes Business Description

Address Cidade de Deus. Predio Amarelo, 2nd Floor, Osasco, SP, BRA, 6029900
D1000 Varejo Farma Participacoes SA invests in national or foreign pharmaceutical retail companies.
78GF Score

Get the complete analysis for BSP:DMVF3

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$6.82
Price
R$8.13
GF Value